Adjuvant and neoadjuvant therapy for early stage: Non-small cell lung cancer

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Lung cancer is the number one cause of cancer-related death in both men and women in the United States. Non-small cell lung cancer accounts for approximately 85% of these cases. Despite complete resection, long-term survival for patients with operable disease remains poor. Studies exploring postoperative chemotherapy have not shown improved survival. Preoperative chemotherapy has shown promise in stage III disease and is currently under investigation for patients with early stage non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)23-28
Number of pages6
JournalSeminars in oncology
Volume28
Issue number4 SUPPL. 14
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Adjuvant and neoadjuvant therapy for early stage: Non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this